While BLFs treatment reduced Rab7 and Hif3α levels following circadian disruption in both cohorts, it did not significantly alter their expression in AD mice without circadian disruption, suggesting that BLFs may primarily alleviate circadian disruption stress rather than AD pathology alone. Here, HIF3A is linked to Alzheimer disease.